FAM110A could serve as a prognostic biomarker for patients with breast cancer: A comprehensive analysis by integrating bulk and single-cell sequencing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FAM110A could serve as a prognostic biomarker for patients with breast cancer: A comprehensive analysis by integrating bulk and single-cell sequencing

Published:2024-09 Issue:9 Volume:47 Page:4036-4038
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Ni Qian,Zhang Huijuan^ORCID,Liu Jiannan,Sun Ping

Publisher

Elsevier BV

Reference5 articles.

1. Clinical implications and immune implications features of TARS1 in breast cancer;Gui;Front Oncol,2023

2. Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment;Xu;iScience,2023

3. Landscape of immune microenvironment under immune cell infiltration pattern in breast cancer;Xu;Front Immunol,2021

4. Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer;Zhong;Front Immunol,2023

5. TSPAN1-elevated FAM110A promotes pancreatic cancer progression by transcriptionally regulating HIST1H2BK;Huang;J Cancer,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP